Llwytho...

Investigation of a Thromboxane A(2) Receptor–Based Vaccine for Managing Thrombogenesis

BACKGROUND: Despite the well‐established role for the thromboxane A(2) receptor (TPR) in the development of thrombotic disorders, none of the antagonists developed to date has been approved for clinical use. To this end, we have previously shown that an antibody targeted against TPR's ligand‐bi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Am Heart Assoc
Prif Awduron: Alshbool, Fatima Z., Karim, Zubair A., Espinosa, Enma V. Paez, Lin, Olivia A., Khasawneh, Fadi T.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2018
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6064912/
https://ncbi.nlm.nih.gov/pubmed/29936414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.009139
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!